Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 6,128

Document Document Title
WO/2007/093292A3
Certain substituted amino heterocyclic and heteroaryl derivatives have provided unexpected insecticidal and acaricidal activity. These compounds are represented by formula (I): wherein R, R1, R2, R3, R4, A, B and Q are fully described he...  
WO/2007/137107A3
The present invention relates to compounds of formula (I) wherein R1, R3, X, Q, Z, A, D, m, and n are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.  
WO/2008/000969A1
The invention relates to compounds of formula (I) wherein R1 is an R4 or NHR4 grouping wherein R4 has the designation defined in the description; R2 is a straight or branched substituted alkyl grouping (C1-C6); and R3 is a hydrogen or ha...  
WO2006122782A8
N-(2-hydroxyalkanoyl) -N, N' -dialkylureas of general formula (I) are described A-X-(A)n, where A: m = 0 or m = 1; when m = 0, X = R''', where R''' is an aliphatic, cycloaliphatic, arylaliphatic radical, C1-C18; when m = 1, X = -(CH2)n-,...  
WO/2007/141423A1
The invention concerns phenoxy-isobutyric acid derivatives of general formula (I) wherein: R1 and R2 are H, an alkyl group, or a -OR group where R is an alkyl, or R1 and R2 together form a hydrocarbon ring of 3 to 6 carbon atoms; R3 is H...  
WO/2007/137107A2
The present invention relates to compounds of formula (I) wherein R1, R3, X, Q, Z, A, D, m, and n are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.  
WO/2007/134971A1
The invention relates to benzoyl-substituted alanines of formula (I), in which the variables R1 to R13 are defined as cited in the description, and to their agriculturally useful salts. The invention also relates to methods and intermedi...  
WO/2007/137103A2
The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, m, n, p and q are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.  
WO/2007/137029A1
Compounds of the formula (I) or a pharmaceutically acceptable salt thereof or a tautomer thereof, wherein A and B are as described herein, are useful for treating conditions afflicting mammals.  
WO/2007/084882A3
Disclosed is an improved multi-step process for preparing a compound of Formula I and intermediates used therein: (I) wherein R1 to R3 are as defined herein. The compounds of formula I inhibit the binding of human intercellular adhesion ...  
WO/2007/133531A2
A composition comprising a self-emulsifiable or self-dispersible aqueous solution or dispersion of at least one urea linkage-containing alkoxypolyoxyalkylene fluorocarbamate prepared by contacting (a) at least one polyisocyanate which co...  
WO/2007/131336A1
This invention relates to iodonium salts, acetal copolymers and polymer binders comprising functional groups capable of undergoing cationic or radical polymerization, their method of preparation and their use in the preparation of coatin...  
WO/2007/056469A3
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.  
WO/2007/130898A1
The present invention relates to tetra-substituted urea compounds which are modulators of 11-β hydroxyl steroid dehydrogenase type 1 (11β HSD1), their pharmaceutical compositions, and methods of using the same.  
WO/2007/124898A1
This invention is directed to compounds of formula (I): to pharmaceutical compositions comprising them; to combination products comprising them; and to their use in therapy.  
WO2007107352A8
The present invention provides novel compounds that inhibit cell proliferation, in particular through the disruption of chromosome segregation and uses of these compounds for treating, ameliorating or preventing diseases, conditions or d...  
WO/2007/122847A1
A reagent for organic syntheses with which a chemical reaction can be conducted in a liquid phase and unnecessary compound(s) can be easily separated at low cost from the liquid phase after completion of the reaction. The reagent for org...  
WO/2007/119042A2
The present invention relates to a process for the treatment of a product stream, more specifically of a product stream from an autothermal cracking process, said product stream comprising one or more olefins, hydrogen, carbon monoxide, ...  
WO/2007/049158A3
The invention relates to novel biaromatic derivatives, which are modulators of peroxisome proliferator-activated receptors, known as PPAR, of formula (I). The invention also relates to the process for preparing them and to their use in p...  
WO/2007/107352A1
The present invention provides novel compounds that inhibit cell proliferation, in particular through the disruption of chromosome segregation and uses of these compounds for treating, ameliorating or preventing diseases, conditions or d...  
WO/2007/105793A1
Disclosed is a method for commercially advantageously producing an N-nitroisourea, which is useful as a synthetic intermediate for pharmaceutical products and agricultural chemicals, or a salt of such an N-nitroisourea. Specifically disc...  
WO/2007/106525A1
Compounds of the formula (I); wherein R1 is a member selected from the group consisting of C1-C8alkyl, arylC0-C8alkyl, C3-C12cycloalkyl and heterocyclyl, Y1 is selected from the group consisting of a bond, C(R5)2, NR5 and O; Y2 is select...  
WO/2007/105050A1
Dibenzyl amine compounds and derivatives, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain oth...  
WO/2007/103485A2
The present invention relates to methods, kits, and compositions for purifying small RNA molecules. In particular, the present invention provides methods for purifying small RNA molecules from a sample containing both small RNA molecules...  
WO/2007/029155A3
The present invention relates to an improved process for preparing pure celiprolol base in monohydrate form by crystallizing crude celiprolol base in one or more carboxylic acid ester solvents and its conversion to pharmaceutically accep...  
WO/2007/093211A1
The invention relates to a process for the treatment of an aqueous mixture comprising a dipolar aprotic compound, comprising: a) an adsorption step, in which the aqueous mixture is brought into contact with a porous adsorbent, whereby th...  
WO/2007/091390A1
Disclosed is an improved method for producing a nitroisourea derivative which is necessary for producing a nitroguanidine derivative having an insecticidal activity. Specifically disclosed is a method for producing a nitroisourea derivat...  
WO2006084688A8
Compounds of the formula (I): Wherein R1, R2, X and N are as defined in the specification; E is N, CH; A1 and A" are terminal groups as defined in the specification. The compounds have utility as HIV-I protease inhibitors.  
WO/2007/046513A3
The present invention relates to a benzoylurea compound represented by formula (I), wherein X and Y represent a fluorine atom or a chlorine atom, R1 represents a lower alkyl group or the like, R2 represents a lower alkyl group, R3 repres...  
WO2004007437A9
The invention relates to urea-substituted and urethane-substituted acylureas, to physiologically compatible salts thereof and to their physiologically functional derivatives. The invention thus relates to compounds of formula (I), wherei...  
WO/2007/091392A1
Disclosed is an industrially advantageous process for production of O-methyl-N-nitroisourea. O-methyl-N-nitroisourea of the formula (1) or a salt thereof can be produced in a high yield by performing the nitration of O-methylisourea of t...  
WO/2007/068394A3
The invention relates to novel specifically trifluoromethyl and halogen substituted 1 ,3- diphenyl ureas and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects l...  
WO/2007/084882A2
Disclosed is an improved multi-step process for preparing a compound of Formula I and intermediates used therein: (I) wherein R1 to R3 are as defined herein. The compounds of formula I inhibit the binding of human intercellular adhesion ...  
WO/2007/080109A1
The present invention relates to novel substituted benzyloxy-phenylmethylurea derivatives, processes for their preparation, and their use in medicaments, especially for the prophylaxis and treatment of diseases associated with Cold Menth...  
WO/2007/079930A1
The present invention relates to substituted cyclohexylmethyl derivatives, to processes for preparing them, to pharmaceuticals comprising these compounds, and to the use of substituted cyclohexylmethyl derivatives for producing pharmaceu...  
WO/2007/019308A3
Acylfulvene analogs, which inhibit tumor growth, especially solid tumor growth, and which have an adequate therapeutic index to be effective for in vivo treatment are provided herein. The compounds described herein are useful as anti-neo...  
WO/2007/002639A3
The present disclosure provides amide-based, non-nucleoside compounds having antiviral activity against Hepacivirus, such as hepatitis C virus (HCV) , methods and intermediates for synthesizing such compounds, and methods of using the co...  
WO/2007/068394A2
The invention relates to novel specifically trifluoromethyl and halogen substituted 1 ,3- diphenyl ureas and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects l...  
WO/2007/068395A1
The invention relates to novel specifically trifluoromethyl and halogen substituted 1,3-diphenyl ureas and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects lik...  
WO/2007/068330A1
The present invention relates to 2-adamantylurea derivatives of formula (I) as selective inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and the use of such compounds for the treatment and prevention of m...  
WO/2007/066496A1
The present invention relates to a benzoylurea compound represented by the formula (1): wherein R2 represents a lower alkylene group etc., and A represents a group represented by OR3, S(O) nR4 or NR5R6, or a salt thereof, and use of the ...  
WO/2007/064273A1
The present invention relates to compounds of formula (I) and processes for preparing such compounds, their use in the treatment of obesity, psychiatric and neurological disorders, to methods for their therapeutic use and to pharmaceutic...  
WO/2007/062308A2
Compounds of formula (Ia) and (Ib) wherein A, B, C and R1 are described herein. The compounds (Ia) and (Ib) are useful as CETP inhibitors.  
WO2007002635B1
The present invention provides novel C-linked cyclic compounds and analogues of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, D and W are as defined herein...  
WO/2007/056469A2
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.  
WO/2007/013811A3
The present invention in a first aspect relates to flavour modulation in foodstuffs, beverages, tobacco products and oral care products, using a flavour modulating substance selected from the group represented by formula (I), edible salt...  
WO/2007/048771A1
A compound of formula (I), wherein substituents are as given above, useful in the treatment of a disease mediated by the action of CCR3, in particular inflammatory or obstructive airway diseases.  
WO/2006/122072A3
The present invention relates to processes for preparing biaryl ureas derivatives and analogs thereof. The invention also provides compounds useful as intermediates in the processes of the present invention. The process is useful for pre...  
WO/2007/049656A1
Disclosed are a novel fluoroadamantane derivative and a method for producing the same. Specifically disclosed are a method for producing a compound (2) shown below wherein a compound (1) shown below is reacted with an azide and then subj...  
WO/2007/049158A2
The invention relates to novel biaromatic derivatives, which are modulators of peroxisome proliferator-activated receptors, known as PPAR, of formula (I). The invention also relates to the process for preparing them and to their use in p...  

Matches 401 - 450 out of 6,128